A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults
Clinical trial NCT04062669 · COMPLETED
Trial details
- NCT number
- NCT04062669
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-13
- Primary completion
- 2021-07-28
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.